Commun Dis Intell. 2000 Sep;24(9):269-71. doi: 10.33321/cdi.2000.24.46.
A long-term programme of surveillance of antimicrobial resistance in Neisseria gonorrhoeae isolated in the World Health Organization's Western Pacific Region Gonococcal Antimicrobial Surveillance Programme ((WHO WPR GASP) continued in 1999. Over 10,000 gonococci were examined in 18 focal centres. Resistance to the quinolones and penicillins was already high in many parts of the Western Pacific Region and increased further in most centres, the exceptions being a number of Pacific Island States. Although resistance to the later generation cephalosporins was absent, and that to spectinomycin infrequent, options for effective treatment of gonorrhoea in the Western Pacific Region continue to be limited.
世界卫生组织西太平洋地区淋球菌抗菌药物监测项目（WHO WPR GASP）中对分离出的淋病奈瑟菌进行抗菌药物耐药性长期监测的项目于1999年继续开展。18个重点中心检测了10000多株淋球菌。西太平洋地区许多地方对喹诺酮类和青霉素类的耐药性已经很高，且在大多数中心进一步上升，一些太平洋岛国是例外。虽然对新一代头孢菌素没有耐药性，对壮观霉素的耐药性也很少见，但西太平洋地区淋病的有效治疗选择仍然有限。
